CBD Industry News Now
SEE OTHER BRANDS

The latest news on CBD

Chicago Atlantic BDC, Inc. Reports Second Quarter 2025 Financial Results

NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the second quarter ended June 30, 2025.

Second Quarter 2025 Highlights and Subsequent Activity

  • Total gross investment income of $13.1 million
  • Net investment income of $7.7 million, or $0.34 per weighted average share outstanding
  • Total investment portfolio of $307.5 million at fair value
  • Net asset value (“NAV”) per share was $13.23 on June 30, 2025
  • Declared a dividend of $0.34 per share for the quarter ending September 30, 2025 payable on October 10, 2025 to shareholders of record of September 29, 2025
  • Funded nine portfolio companies with $39.1 million in aggregate par value during the second quarter of 2025
  • Subsequent to quarter end, the Company funded $17.2 million in investments across five borrowers
  • As of June 30, 2025, there were 22,820,408 common shares issued and outstanding on a basic and fully diluted basis

Peter Sack, Chief Executive Officer of the Company, commented, “Through a consistent and measured approach, we deployed $56 million in gross fundings by principal value during the second quarter and to date in the third quarter. These investments were partially funded with borrowings on our new senior credit facility. With the originations pipeline of cannabis and non-cannabis opportunities growing to over $780 million across the Chicago Atlantic platform, we believe the credit facility will provide a distinct advantage in meeting the needs for borrowers’ upcoming debt maturities, growth capital and potential ESOP transactions.”

Portfolio and Investment Activity

  • As of June 30, 2025, the Company’s investment portfolio had an aggregate fair value of approximately $307.5 million across 31 portfolio companies.
  • During the quarter ended June 30, 2025, the Company funded nine portfolio companies with an aggregate par value of $39.1 million, three of which were in new borrowers. Subsequent to quarter end, the Company funded five investments with an aggregate par value of $17.2 million, three of which were to new borrowers.
  • During the quarter ended June 30, 2025, the Company had principal repayments of $22.3 million of which $3.1 million was receivable as of June 30, 2025.
  • As of June 30, 2025, there were no loans on non-accrual status.

Results of Operations

For the three months ended June 30, 2025, total investment income was approximately $13.1 million. For the three months ended June 30, 2025, the Company incurred net expenses of approximately $5.4 million, resulting in net investment income of approximately $7.7 million, or $0.34 per weighted average share, and a net increase in net assets from operations of approximately $8.6 million, or $0.38 per weighted average share.

Liquidity and Capital Resources

As of June 30, 2025, the Company had $108.8 million of liquidity including $13.8 million of cash and cash equivalents and $5.0 million of borrowings outstanding on its $100 million senior credit facility. As of August, 14 2025 the Company has no outstanding borrowings on its senior credit facility and $125.4 million of liquidity.

Net Asset Value

As of June 30, 2025, NAV per share was $13.23 compared with $13.19 as of March 31, 2025. The slight increase in NAV per share was primarily driven by growth in net assets from operations, offset by dividend payments. Total net assets as of June 30, 2025 were $301.8 million compared to $301.0 million as of March 31, 2025.

Dividend

The Company’s Board of Directors declared a cash dividend of $0.34 per share for the quarter ending September 30, 2025 payable on October 10, 2025 to shareholders of record of September 29, 2025.

Conference Call and Quarterly Earnings Presentation

The Company will host a conference call and live audio webcast, both open for the general public to hear, to discuss the Company's second quarter 2025 financial results at 9:00 a.m. Eastern Time on Thursday, August 14, 2025. The number to call for the conference call is (833) 630-1956 (international callers: 412-317-1837). The live audio webcast of the call will also be available on the Company’s website at lien.chicagoatlantic.com.

A replay of the call will be available at lien.chicagoatlantic.com by the end of day on August 14, 2025.

Call Details – Chicago Atlantic BDC, Inc. Second Quarter 2025 Financial Results:

LIEN posted its Second Quarter 2025 Earnings Presentation on the Events and Presentations page of its website, lien.chicagoatlantic.com. LIEN routinely posts important information for investors on its website. The Company intends to use this website as a means of disclosing material information, for complying with our disclosure obligations under Regulation FD and to post and update investor presentations and similar materials on a regular basis. The Company encourages investors, analysts, the media and others interested in LIEN to monitor the Investor Relations page of its website, in addition to following its press releases, Securities and Exchange Commission (“SEC”) filings, publicly available earnings calls, presentations, webcasts and other information posted from time to time on the website. Please visit the IR Resources section of the website to sign up for email notifications.

About Chicago Atlantic BDC, Inc.

The Company is a specialty finance company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended, and has elected to be treated as a regulated investment company for U.S. federal income tax purposes. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a primary focus on cannabis companies. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis industry and other niche or underfollowed sectors. For more information, please visit lien.chicagoatlantic.com.

Forward-Looking Statements

Certain information contained herein may constitute “forward-looking statements” that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about the Company, its current and prospective portfolio investments, its industry, its beliefs and opinions, and its assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the Company’s control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements including, without limitation, the risks, uncertainties and other factors identified in the Company’s filings with the SEC. Investors should not place undue reliance on these forward-looking statements, which apply only as of the date on which the Company makes them. The Company does not undertake any obligation to update or revise any forward-looking statements or any other information contained herein, except as required by applicable law.

Contact
Tripp Sullivan
Lisa Kampf
SCR Partners
LIEN@chicagoatlantic.com


CHICAGO ATLANTIC BDC, INC.
Statements of Assets and Liabilities

  June 30, 2025   March 31, 2025  
  (Unaudited)   (Unaudited)  
ASSETS        
Investments at fair value:        
Non-control/non-affiliate investments at fair value (amortized cost of $305,718,723 and $288,402,119, respectively) $ 307,499,004     $ 289,262,741    
Cash and cash equivalents   13,829,354       14,921,739    
Due from affiliates   6,517,715       5,202,278    
Interest receivable   2,480,774       3,061,836    
Prepaid expenses and other assets   1,423,572       1,250,109    
Total assets $ 331,750,419     $ 313,698,703    
             
LIABILITIES            
Payable for Investments Purchased $ 11,760,000     $ -    
Distributions payable   7,758,939       7,758,931    
Revolving line of credit   5,000,000       -    
Income-based incentive fees payable   1,968,640       2,122,865    
Management fee payable   1,345,331       1,339,250    
Due to affiliates   724,306       197,344    
Professional fees payable   629,000       756,602    
Capital gains incentive fees payable   299,006       115,074    
Other payables   155,002       62,816    
Unearned interest income   126,136       213,269    
Offering costs payable   92,615       -    
Deferred financing costs payable   47,881       114,548    
Total liabilities $ 29,906,856     $ 12,680,699    
             
Commitments and contingencies (Note 6)            
             
 NET ASSETS            
Common stock, $0.01 par value, 100,000,000 shares authorized, 22,820,408 and 22,820,386 shares issued and outstanding, respectively $ 228,204     $ 228,204    
Additional paid-in-capital   303,152,264       303,152,031    
Distributable earnings (accumulated loss)          (1,536,905 )     (2,362,231 )  
Total net assets $ 301,843,563     $ 301,018,004    
NET ASSET VALUE PER SHARE $ 13.23     $ 13.19    


CHICAGO ATLANTIC BDC, INC.
Statements of Operations
(Unaudited)
    For the Three Months Ended    
    June 30,
2025
      March 31,
2025
   
INVESTMENT INCOME                
Non-control/non-affiliate investment income                
Interest income   $ 11,906,066     $ 11,279,456    
Fee income     1,173,972       643,546    
Total investment income     13,080,038       11,923,002    
                   
EXPENSES                  
Income-based incentive fees     1,968,637       1,916,277    
General and administrative expense     1,366,783       974,477    
Management fee     1,345,331       1,260,875    
Legal expenses     313,139       250,926    
Interest expense     301,260       145,381    
Professional fees     275,860       215,726    
Capital gains incentive fees     183,932       (6,813 )  
Other expenses     169,717               144,422    
Audit expense     153,750       190,002    
Sub-administrator fees     128,805       157,785    
Transaction expenses related to the Loan Portfolio Acquisition     -       -    
Excise tax expense     -       -    
Total expenses     6,207,214       5,249,058    
Waiver of General and administrative expense     -       (658,477  
Expense limitation agreement     (791,783 )     (316,000  
Net expenses     5,415,431       4,274,581    
NET INVESTMENT INCOME (LOSS)     7,664,607       7,648,421    
                   
NET REALIZED GAIN (LOSS) FROM INVESTMENTS                  
Non-controlled non-affiliate investments     -       -    
Net realized gain (loss) from investments     -       -    
                   
NET CHANGE IN UNREALIZED APPRECIATION (DEPRECIATION) ON INVESTMENTS                  
Non-controlled/non-affiliate investments     919,658       (34,064 )  
Net change in unrealized appreciation (depreciation) on investments     919,658       (34,064 )  
Net realized and unrealized gains (losses)     919,658       (34,064 )  
                   
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS   $ 8,584,265     $ 7,614,357    
                   
NET INVESTMENT INCOME (LOSS) PER SHARE - BASIC AND DILUTED   $ 0.34     $ 0.34    
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC AND DILUTED   $ 0.38     $ 0.33    
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED     22,820,405       22,820,386    

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions